Answers - Real Estate

Adjustable Rate Mortgage Popularity

Over the last five years almost forty percent of all home buyers selected adjustable rate mortgages. In early 2004 signs of inflation begin to appear. These indications pressed the Federal R

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

eserve into action. From June 2004 to June of 2006 the Federal Reserve increased the Federal Funds Rate 17 times. The impact of these increases was to push up the short-term mortgages indexes that determine the target or fully indexed

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

rate on these adjustable rate mortgages. Borrowers that enjoyed the benefits of these low payment mortgage products are now finding themselves with considerably higher interest rates as their mortgages adjust.

Short Term Rates Up<

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

/b>

This interest rate environment has a silver lining. The intent of the Federal Reserve’s actions during this period of time was to contain inflationary forces that would have resulted in higher long-term interest rates. As of this

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

moment, the Federal Reserve has been successful and long-term mortgage rates have remained near historic lows. The Federal Reserve has been so effective that long term rates such as thirty-year mortgages are now lower than adjustable

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ate mortgage offerings.

Long Term Rates Down

The anomaly of long term rates falling below short term rates is referred to by economists as an inverted yield curve. This phenomenon is currently providing the best possible refi

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

nance environment for borrowers that have recently experienced an increase in their adjustable mortgage rates. No one has been happy about watching their monthly payment increase. But imagine the alternative scenario where short and l

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ng term rates might have moved up together making it impossible for borrowers to refinance into an affordable mortgage.

Option ARM Concerns

One of the most popular mortgage programs of this period of time was the negative amo

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

tization loan. This loan type has been branded by many different names including the Option ARM. This loan allows borrowers to make a payment based on an interest rate that is often significantly below the effective, or fully indexed,

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

rate. Borrowers selecting this low payment option find themselves owning more than they originally borrowed. Florida Mortgage brokers originated significant numbers of these mortgages as real estate values soared and buyers were eage

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

to find ways to make their home payments affordable.

The New Fixed Rate Interest Only Mortgage

A new product has emerged that has become a terrifically popular option for borrowers wishing to refinance and to keep their home

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

loan payments at a minimum. This program is the new thirty year fixed rate interest only mortgage. Interest only mortgages allow a borrower to pay only the interest due on a loan thereby minimizing their payments. Until very recently

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

these interest only programs were only available on adjustable rate mortgages. That meant that in a short period of time, ranging from two to five years, the interest only feature would expire and the rate would adjust. This combinati

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

n of events has the potential of more than doubling a borrower’s monthly payment.

A Caveat

This new breed of fixed rate interest only mortgage combines the security of a fixed rate mortgage with an attractive low interest onl

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

payment. Like previous versions of interest only programs the interest only period is for a finite period of time. These new programs have improved on this aspect of the mortgage as well by extending the interest only period to ten y

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ears. There is one caveat to be aware of. Although the rate will remain fixed when the loan transitions from an interest only loan to a fully amortized loan at the end of ten years, the amortization period is limited to the remaining

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

wenty years. The change from an interest only payment to a twenty year amortized payment will be noticeable and should be planned for.

Market Factors

Another factor that is driving this move to refinance is the weakened real

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

state market. As a Florida mortgage broker I have seen a significant increase in the number of borrowers that have decided against selling their homes, opting instead to refinance. Refinancing into an interest only program for many bo

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

rrowers is the most attractive option. Many of these same people are refinancing out of their negative amortization loans wishing to keep their payment at a minimum and at the same time put an end to the reverse amortization effect of

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

their current mortgages. The weakening real estate market has further underlined the importance of maintaining equity. There is little that we can do about market forces, but we do have control over the mortgage options that we choose

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Answers - Florida Mortgage Broker Discusses Interest Only Refinance Options

Related Articles: